STOCK TITAN
  1. Home
  2. Sec-filings
  3. CFLT
  4. [Form 4] Confluent, Inc. Insider Trading Activity

Confluent, Inc. (CFLT) director reports option exercise and Class A sale

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Confluent, Inc. director reported equity transactions on December 10, 2025. The director exercised stock options to buy 23,100 shares of Class B common stock at $2.24 per share, which converted into an equal number of Class A shares. The director then sold 23,100 Class A shares at prices ranging from $30.00 to $30.02 under a Rule 10b5-1 trading plan adopted June 10, 2025. After these trades, the director held 28,549 Class A shares directly and 1,787 Class A shares indirectly through a trust.

Positive

  • None.

Negative

  • None.
Insider Narkhede Neha
Role Director
Sold 23,100 shs ($693K)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 23,100 $0.00 --
Exercise Class B Common Stock 23,100 $0.00 --
Conversion Class B Common Stock 23,100 $0.00 --
Conversion Class A Common Stock 23,100 $0.00 --
Sale Class A Common Stock 23,100 $30.00 $693K
holding Class A Common Stock -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 457,502 shares (Direct); Class B Common Stock — 1,106,829 shares (Direct); Class A Common Stock — 51,649 shares (Direct); Class A Common Stock — 1,787 shares (Indirect, By Trust)
Footnotes (1)
  1. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock. Shares sold pursuant to a 10b5-1 plan adopted June 10, 2025. The shares were sold at prices ranging from $30.00 to $30.02. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Fully vested.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Narkhede Neha
(Last) (First) (Middle)
C/O CONFLUENT, INC.
899 W. EVELYN AVENUE
(Street)
MOUNTAIN VIEW CA 94041
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Confluent, Inc. [ CFLT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 12/10/2025 C 23,100 A (1) 51,649 D
Class A Common Stock 12/10/2025 S 23,100(2) D $30(3) 28,549 D
Class A Common Stock 1,787 I By Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $2.24 12/10/2025 M 23,100 (4) 10/21/2028 Class B Common Stock 23,100 $0 457,502 D
Class B Common Stock (1) 12/10/2025 M 23,100 (1) (1) Class A Common Stock 23,100 $0 1,106,829 D
Class B Common Stock (1) 12/10/2025 C 23,100 (1) (1) Class A Common Stock 23,100 $0 1,083,729 D
Explanation of Responses:
1. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock.
2. Shares sold pursuant to a 10b5-1 plan adopted June 10, 2025.
3. The shares were sold at prices ranging from $30.00 to $30.02. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. Fully vested.
/s/ Weilyn Wood, Attorney-in-Fact 12/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did a Confluent (CFLT) director report?

A Confluent director exercised stock options to acquire 23,100 Class B common shares at $2.24 each, which converted into Class A shares, and then sold 23,100 Class A shares on December 10, 2025.

How many Confluent (CFLT) Class A shares were sold and at what prices?

The director sold 23,100 shares of Confluent Class A common stock at prices ranging from $30.00 to $30.02.

Was the Confluent (CFLT) share sale made under a Rule 10b5-1 plan?

Yes. The 23,100 Class A shares were sold pursuant to a Rule 10b5-1 trading plan that was adopted on June 10, 2025.

How many Confluent (CFLT) Class A shares does the director own after the transaction?

After the reported transactions, the director beneficially owns 28,549 Class A shares directly and 1,787 Class A shares indirectly through a trust.

What are the details of the Confluent director’s stock options involved in this filing?

The director exercised a fully vested stock option for 23,100 shares with an exercise price of $2.24 per share, expiring on October 21, 2028, with the underlying security listed as Class B common stock.

How do Confluent (CFLT) Class B shares relate to Class A shares in this report?

Each share of Confluent Class B common stock held by the director is convertible into one share of Class A common stock, including automatic conversion upon sale or transfer and optional conversion at any time.